4//SEC Filing
Wallace Steven P. 4
Accession 0001235802-19-000139
CIK 0001492658other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:51 PM ET
Size
18.0 KB
Accession
0001235802-19-000139
Insider Transaction Report
Form 4
Wallace Steven P.
President, International
Transactions
- Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-12-05$26.81/sh+7,634$204,668→ 21,649 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-12-05$27.86/sh+5,412$150,778→ 27,061 total - Sale
Ordinary Shares, par value EUR 0.03 per share
2019-12-05$29.60/sh−17,222$509,773→ 14,015 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-05−4,176→ 8,360 totalExercise: $24.49Exp: 2028-07-24→ Ordinary Shares (4,176 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-12-05$24.49/sh+4,176$102,270→ 31,237 total - Exercise/Conversion
Stock Option (right to buy)
2019-12-05−7,634→ 3,482 totalExercise: $26.81Exp: 2027-02-16→ Ordinary Shares (7,634 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-12-05−5,412→ 3,875 totalExercise: $27.86Exp: 2027-07-25→ Ordinary Shares (5,412 underlying)
Footnotes (6)
- [F1]Exercise and sale of vested stock options in connection with 280G tax planning
- [F2]Includes 1,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, 5,232 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,939 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.605, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option vested with respect to 25% of the shares on February 16, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F5]This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F6]This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001763512
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:51 PM ET
- Size
- 18.0 KB